Derma Sciences (DSCI) 9.51 $DSCI
Derma Sciences Reports First Quarter Financial Results
Business Wire - Thu May 08, 6:30AM CDT
--Steady progress with DSC127 Phase 3 program, affirms timetable and total cost
Derma Sciences to Present at Sidoti Semiannual Micro-Cap Conference on May 9
Business Wire - Tue May 06, 10:32AM CDT
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, announced today that Edward J. Quilty, the Company's chairman and chief executive officer, will present a corporate overview and update at the Sidoti & Company Semiannual Micro-Cap Conference on Friday, May 9, 2014 at 10:40 a.m. Eastern time. The conference is being held at the Grand Hyatt New York Hotel in New York City.
Derma Sciences to Hold First Quarter Financial Results Conference Call on May 8th
Business Wire - Wed Apr 30, 9:12AM CDT
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on May 8, 2014 to discuss the financial results for the first quarter of 2014. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
3 Stocks Under $10 Making Big Moves
at The Street - Wed Apr 30, 6:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Global Diabetic Foot Ulcers Therapeutics Pipeline Review 2014
M2 - Mon Apr 28, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/423zx2/diabetic_foot) has announced the addition of the "Global Diabetic Foot Ulcers Therapeutics Pipeline Review 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Diabetic Foot Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Derma Sciences, Inc. - Cardium Therapeutics, Inc. - GlaxoSmithKline plc - CardioVascular BioTherapeutics, Inc. - Stratatech Corporation - Photopharmica Limited - Tissue Med Biosciences - Reliance Life Sciences Pvt. Ltd. - Nanotherapeutics, Inc. - Celgene Corporation - Kaken Pharmaceutical Co., Ltd. - CytoTools AG - Indus Biotech Private Limited - Phage Pharmaceuticals, Inc. - NovaLead Pharma Pvt. Ltd. - FirstString Research, Inc. - Theravasc, Inc. - CoDa Therapeutics, Inc. - Adocia - EyeGene, Inc. - Izun Pharmaceuticals Corporation - Praxis Pharmaceuticals Inc. - Oneness Biotech Co., Ltd. - Aprogen, Inc. - Pergamum AB - Dipexium Pharmaceuticals LLC - Kasiak Research Pvt. Ltd. Drug Profiles - pexiganan acetate - DermaPro CI-05 - trafermin - WH-1 - DSC-127 - CVBT-141B - doxycycline - GAM-501 - Biochaperone PDGF-BB - CODA-001 - PX-070101 - ReliDerm-DT - PPA-904 - IZN-6D4 - Granexin - CSTC-1 - esmolol hydrochloride - gentamicin sulfate - GSK-1278863 - Fibroblast Growth Factor-1 - PDA-002 - TMBP-3 - coagulation factor XIVa (human) - rusalatide acetate - INDUS-820 - VLD-02 - AP-102 - Drug For Wound Healing - Stromal Cell Therapy For Diabetic Complications - EG-Decorin - Nu-2 - MT-003 - CA5-HIF Gene Therapy for Wound and Ulcers - Cathelicidin - Drug For Diabetic Foot Ulcer - LL-37 - Refaheal For more information visit http://www.researchandmarkets.com/research/42...betic_foot
Derma Sciences Products to Be Featured in 10 Posters and Two Educational Programs at the SAWC Conference; Company Launches New Corporate Branding Campaign
Business Wire - Wed Apr 23, 6:30AM CDT
Derma Sciences, Inc. (Nasdaq SCI), a tissue regeneration company focused on advanced wound care, announces that its products are the subject of 10 poster presentations and abstracts to be featured at the Spring Symposium on Advanced Wound Care (SAWC). Derma Sciences also announces a new corporate branding campaign focused on driving awareness of the company's leadership in tissue regeneration and wound healing. This campaign features a new corporate logo and the "A Tissue Regeneration Company" tagline, and will debut at the SAWC and at the 2014 MedAssets Healthcare Business Summit, two important conferences being held this week for clinicians dedicated to wound healing.
Global Advanced Wound Management Market Forecasts & Opportunities, 2019
M2 - Thu Apr 10, 3:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w7fq2g/advanced_wound) has announced the addition of the "Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth" report to their offering. The global advanced wound management market will reach a value of $4.4 billion in 2019 from $3.1 billion in 2012, climbing at a Compound Annual Growth Rate (CAGR) of 5.7%. Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth looks at the market, competitive landscape, and trends for eight advanced wound dressing segments: foams, hydrocolloids, hydrogels, semi-permeable films, hydrofibers, wound contact layers, alginates, and collagens. The report provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment's pipeline products, as well as details of important M&A deals. Scope - Key geographies of the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil - Information on market size for eight advanced wound management market segments: foams, hydrocolloids, hydrogels, semi-permeable films, hydrofibers, wound contact layers, alginates, and collagens - Annualized market revenue data forecast to 2019 and company share data for 2011 - Qualitative analysis of key trends in the advanced wound management market - Information on the leading market players, the competitive landscape, and the leading technologies Key Topics Covered: - Tables & Figures - Introduction - Device Overview - Market Characterization - Segment Analysis and Forecasts - Country Analysis and Forecasts - Reimbursement System - Distribution System - Competitive Assessment - Product Pipeline Analysis - Consolidation Landscape - Appendix Companies Mentioned - 3M Health Care - B. Braun Melsungen - BSN medical GmbH - Coloplast - ConvaTec - Covidien - Derma Sciences - Laboratoires Urgo - M?lnlycke Health Care - Paul Hartmann - Smith & Nephew - Systagenix Wound Management For more information visit http://www.researchandmarkets.com/research/w7...nced_wound
Traditional Wound Management Products - Global Strategic Business Report 2014-2020
M2 - Tue Mar 18, 11:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xfhww3/traditional_wound) has announced the addition of the "Traditional Wound Management Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Traditional Wound Management Products in US$ Million by the following Product Segments: Adhesive Bandages, Topical Ointments, and Gauzes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. The report profiles 129 companies including many key and niche players such as: - B.Braun Melsungen AG - Beiersdorf AG - Cremer S.A - Covidien Plc - Derma Sciences, Inc. - Johnson & Johnson Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. MARKET TRENDS AND ISSUES 3. PRODUCT OVERVIEW 4. RECENT INDUSTRY ACTIVITY 5. FOCUS ON SELECT GLOBAL PLAYERS 6. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 129 (including Divisions/Subsidiaries - 156) - The United States (86) - Canada (7) - Japan (2) - Europe (40) - - France (3) - - Germany (17) - - The United Kingdom (10) - - Italy (1) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (13) - Latin America (5) - Middle East (3) For more information visit http://www.researchandmarkets.com/research/xf...onal_wound About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products
Business Wire - Fri Mar 14, 6:30AM CDT
Derma Sciences, Inc. (the "Company"
(Nasdaq SCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ended December 31, 2013. Highlights of the fourth quarter of 2013 and recent weeks include:
Wound Debridement Products - Global Strategic Business Report
M2 - Wed Mar 12, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ffjwkx/wound_debridement) has announced the addition of the "Wound Debridement Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 35 companies including many key and niche players such as: - Advanced Medical Solutions Group plc - ArthroCare Corporation - Coloplast A/S - Derma Sciences, Inc. - Misonix, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends And Issues 3. Product Overview 4. Strategic Corporate Developments 5. Focus On Select Global Players 6. Global Market Perspective III. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/ff...ebridement About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 14th
Business Wire - Mon Mar 10, 6:30AM CDT
Derma Sciences, Inc. (the "Company" (Nasdaq SCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on March 14, 2014 to discuss the financial results for the fourth quarter of 2013. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Derma Sciences to Present at the 26th Annual ROTH Conference
Business Wire - Tue Mar 04, 6:30AM CST
Derma Sciences, Inc. (Nasdaq SCI), a tissue regeneration company focused on advanced wound care, announced today that Edward J. Quilty, the Company's chairman and chief executive officer, will present a corporate overview and update at the 26th Annual ROTH Conference on March 11, 2014 at 3:30 p.m. Pacific time. The conference is being held at the Ritz Carlton, Laguna Niguel in Dana Point, Calif. from March 9 through March 12.
Can Derma Sciences (DSCI) Continue to Rise? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 31, 6:33AM CST
Can Derma Sciences (DSCI) Continue to Rise?
Derma Sciences (DSCI) Jumps: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 8:21AM CST
Derma Sciences Inc. (DSCI) was a big mover last session, as the company saw its shares rise by over 6% on the day.
Derma Sciences Closes $86 Million Underwritten Public Offering of Common Stock, Including Full Over-Allotment
Business Wire - Wed Jan 29, 9:17AM CST
Derma Sciences, Inc. (the "Company" (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the closing of an underwritten public offering of 7,500,000 shares of common stock at a price to the public of $11.50 per share, which includes the exercise of the underwriters' option to purchase 978,261 shares of common stock to cover over-allotments. Piper Jaffray & Co. and Canaccord Genuity Inc. were joint bookrunning managers for the offering. Oppenheimer & Co. Inc. and Roth Capital Partners were financial advisors to the Company.
International Wound Dressings Market - Forecasts to 2018
M2 - Wed Jan 29, 3:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/wgbxbp/wound_dressings) has announced the addition of the "International Wound Dressings Market - Forecasts to 2018" report to their offering. "International Wound Dressings Market - Forecasts to 2018", inspects the different types of segments and sub-segments within the market such as the product types such as traditional wound care which includes sutures, gauze tapes and sponges, surgical cotton swabs and tissue sealants etc. The details also include emerging and advanced technologies such as films, foam dressings, collagen, alginates, hydrocolloids and hydrogels. The market analysis includes the analysis for the major geographical regions; North America, Europe, Asia-Pacific and Rest of the World (RoW). The study entails the emerging economies and regional opportunities that will present themselves in the coming years. In addition, the research also includes the other regional factors that will influence the growth or decline of the market in these regions. The analysis covers a forecast period of 2012 - 2018 which includes the several milestones covered in all the years. This represents several aspects such as the political, economical, environmental, legal factors such as growth of economy, reimbursement and medical policies in various regions. The report is prepared in such a way so as to cover the focus areas of multiple stake-holders such as market players and manufacturers of wound care products, hospitals, doctors, other medical professionals, research institutes, venture capitalists and share holders of public companies. The report is expected to act as a influencing tool to enable stake-holders to make calculated strategic decisions related to their marketing, expansion and penetration, business strategies adopted by them. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Wound Dressings Market Analysis Chapter 4 Traditional Wound Dressings Market Chapter 5 Advanced Wound Dressings Market Chapter 6 Geographical Analysis Chapter 7 Company Profiles Companies Mentioned: - 3M Healthcare - BSN Medical GMBH and Co - Bristol-Myers Squibb - CONVATEC HEALTHCARE - Coloplast - Derma Sciences - Hollister - Johnson & Johnson - Kinetic Concepts - Medline Industries - Paul Hartmann - Smith & Nephew - Systagenix Wound Management For more information visit http://www.researchandmarkets.com/research/wg..._dressings
Nasdaq stocks posting largest volume increases
AP - Fri Jan 24, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Derma Sciences Announces Pricing of Underwritten Public Offering of Common Stock
Business Wire - Fri Jan 24, 8:00AM CST
Derma Sciences, Inc. (the "Company" (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the pricing of an underwritten public offering of 6,521,739 shares of common stock at a price to the public of $11.50 per share. The Company has granted the underwriters a 30-day option to purchase an additional 978,261 shares of common stock to cover over-allotments, if any. The offering is expected to close on or about January 29, 2014, subject to customary closing conditions.
Derma Sciences Announces Commencement of Public Offering of Common Stock
Business Wire - Thu Jan 23, 3:01PM CST
Derma Sciences, Inc. (Nasdaq SCI), a tissue regeneration company focused on advanced wound care, today announced that it intends to offer shares of its common stock in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
2013 Report on the European Wound Care Management Market - Outlook and Forecasts to 2018
M2 - Thu Jan 23, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/x3flwl/europe_wound_care) has announced the addition of the "2013 Report on the European Wound Care Management Market - Outlook and Forecasts to 2018" report to their offering. "2013 Report on the European Wound Care Management Market - Outlook and Forecasts to 2018", provides key market data on the Europe Wound Care Management market - United Kingdom, Germany, France, Italy and Spain. The report provides value (USD million) data for all the market categories - Compression Therapy, Advanced Wound Management, Pressure Relief Devices, Wound Closure Devices, Traditional Wound Management, Ostomy Drainage Bags, Negative Pressure Wound Therapy (NPWT), Tissue Engineering, Wound Debridement Devices and Automated Suturing Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key players covered in this report include Coloplast A/S, Paul Hartmann AG, Smith & Nephew Plc, ConvaTec Inc., Covidien plc, Molnlycke Health Care AB, Kinetic Concepts, Inc., ArjoHuntleigh, medi GmbH & Co. KG, Hill-Rom Holdings, Inc., SIGVARIS, Inc., B. Braun Melsungen AG, Hollister Incorporated, Ethicon, Inc., Takeda Pharmaceuticals International GmbH, Baxter International Inc., Laboratoires Urgo S.A. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Wound Care Management in Europe 4 Wound Care Management In Germany 5 Wound Care Management In France 6 Wound Care Management In United Kingdom 7 Wound Care Management In Italy 8 Wound Care Management In Spain 9 Overview of Key Companies in Europe Wound Care Management Market 10 Wound Care Management Market Pipeline Products 11 Financial Deals Landscape 12 Recent Developments 13 Appendix Companies Mentioned: - 3M Health Care - Advanced Medical Solutions Group - Baxter International - Bsn Medical - Coloplast - Convatec - Covidien - Derma Sciences - Igrobe Rodar - Invacare Corporation - Johnson & Johnson - Julius Zorn - Karomed Limited - Laboratoires Innothera - Laboratoires Urgo - Lohmann & Rauscher Gmbh & Co - Medela - Ossur - Paramount Bed - Paul Hartmann - Sidhil Limited - Smith & Nephew - Synergy Health - Systagenix Wound Management - Talley Group Limited - Thuasne For more information visit http://www.researchandmarkets.com/research/x3...wound_care
Derma Sciences Reports First Quarter Financial Results
Business Wire - Thu May 08, 6:30AM CDT
--Steady progress with DSC127 Phase 3 program, affirms timetable and total cost
Derma Sciences to Present at Sidoti Semiannual Micro-Cap Conference on May 9
Business Wire - Tue May 06, 10:32AM CDT
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, announced today that Edward J. Quilty, the Company's chairman and chief executive officer, will present a corporate overview and update at the Sidoti & Company Semiannual Micro-Cap Conference on Friday, May 9, 2014 at 10:40 a.m. Eastern time. The conference is being held at the Grand Hyatt New York Hotel in New York City.
Derma Sciences to Hold First Quarter Financial Results Conference Call on May 8th
Business Wire - Wed Apr 30, 9:12AM CDT
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on May 8, 2014 to discuss the financial results for the first quarter of 2014. In addition, management will provide a business update and a discussion on recent and upcoming milestones. 3 Stocks Under $10 Making Big Moves
at The Street - Wed Apr 30, 6:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Global Diabetic Foot Ulcers Therapeutics Pipeline Review 2014
M2 - Mon Apr 28, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/423zx2/diabetic_foot) has announced the addition of the "Global Diabetic Foot Ulcers Therapeutics Pipeline Review 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Diabetic Foot Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Derma Sciences, Inc. - Cardium Therapeutics, Inc. - GlaxoSmithKline plc - CardioVascular BioTherapeutics, Inc. - Stratatech Corporation - Photopharmica Limited - Tissue Med Biosciences - Reliance Life Sciences Pvt. Ltd. - Nanotherapeutics, Inc. - Celgene Corporation - Kaken Pharmaceutical Co., Ltd. - CytoTools AG - Indus Biotech Private Limited - Phage Pharmaceuticals, Inc. - NovaLead Pharma Pvt. Ltd. - FirstString Research, Inc. - Theravasc, Inc. - CoDa Therapeutics, Inc. - Adocia - EyeGene, Inc. - Izun Pharmaceuticals Corporation - Praxis Pharmaceuticals Inc. - Oneness Biotech Co., Ltd. - Aprogen, Inc. - Pergamum AB - Dipexium Pharmaceuticals LLC - Kasiak Research Pvt. Ltd. Drug Profiles - pexiganan acetate - DermaPro CI-05 - trafermin - WH-1 - DSC-127 - CVBT-141B - doxycycline - GAM-501 - Biochaperone PDGF-BB - CODA-001 - PX-070101 - ReliDerm-DT - PPA-904 - IZN-6D4 - Granexin - CSTC-1 - esmolol hydrochloride - gentamicin sulfate - GSK-1278863 - Fibroblast Growth Factor-1 - PDA-002 - TMBP-3 - coagulation factor XIVa (human) - rusalatide acetate - INDUS-820 - VLD-02 - AP-102 - Drug For Wound Healing - Stromal Cell Therapy For Diabetic Complications - EG-Decorin - Nu-2 - MT-003 - CA5-HIF Gene Therapy for Wound and Ulcers - Cathelicidin - Drug For Diabetic Foot Ulcer - LL-37 - Refaheal For more information visit http://www.researchandmarkets.com/research/42...betic_foot
Derma Sciences Products to Be Featured in 10 Posters and Two Educational Programs at the SAWC Conference; Company Launches New Corporate Branding Campaign
Business Wire - Wed Apr 23, 6:30AM CDT
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound care, announces that its products are the subject of 10 poster presentations and abstracts to be featured at the Spring Symposium on Advanced Wound Care (SAWC). Derma Sciences also announces a new corporate branding campaign focused on driving awareness of the company's leadership in tissue regeneration and wound healing. This campaign features a new corporate logo and the "A Tissue Regeneration Company" tagline, and will debut at the SAWC and at the 2014 MedAssets Healthcare Business Summit, two important conferences being held this week for clinicians dedicated to wound healing. Global Advanced Wound Management Market Forecasts & Opportunities, 2019
M2 - Thu Apr 10, 3:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w7fq2g/advanced_wound) has announced the addition of the "Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth" report to their offering. The global advanced wound management market will reach a value of $4.4 billion in 2019 from $3.1 billion in 2012, climbing at a Compound Annual Growth Rate (CAGR) of 5.7%. Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth looks at the market, competitive landscape, and trends for eight advanced wound dressing segments: foams, hydrocolloids, hydrogels, semi-permeable films, hydrofibers, wound contact layers, alginates, and collagens. The report provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment's pipeline products, as well as details of important M&A deals. Scope - Key geographies of the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil - Information on market size for eight advanced wound management market segments: foams, hydrocolloids, hydrogels, semi-permeable films, hydrofibers, wound contact layers, alginates, and collagens - Annualized market revenue data forecast to 2019 and company share data for 2011 - Qualitative analysis of key trends in the advanced wound management market - Information on the leading market players, the competitive landscape, and the leading technologies Key Topics Covered: - Tables & Figures - Introduction - Device Overview - Market Characterization - Segment Analysis and Forecasts - Country Analysis and Forecasts - Reimbursement System - Distribution System - Competitive Assessment - Product Pipeline Analysis - Consolidation Landscape - Appendix Companies Mentioned - 3M Health Care - B. Braun Melsungen - BSN medical GmbH - Coloplast - ConvaTec - Covidien - Derma Sciences - Laboratoires Urgo - M?lnlycke Health Care - Paul Hartmann - Smith & Nephew - Systagenix Wound Management For more information visit http://www.researchandmarkets.com/research/w7...nced_wound
Traditional Wound Management Products - Global Strategic Business Report 2014-2020
M2 - Tue Mar 18, 11:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xfhww3/traditional_wound) has announced the addition of the "Traditional Wound Management Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Traditional Wound Management Products in US$ Million by the following Product Segments: Adhesive Bandages, Topical Ointments, and Gauzes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. The report profiles 129 companies including many key and niche players such as: - B.Braun Melsungen AG - Beiersdorf AG - Cremer S.A - Covidien Plc - Derma Sciences, Inc. - Johnson & Johnson Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. MARKET TRENDS AND ISSUES 3. PRODUCT OVERVIEW 4. RECENT INDUSTRY ACTIVITY 5. FOCUS ON SELECT GLOBAL PLAYERS 6. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 129 (including Divisions/Subsidiaries - 156) - The United States (86) - Canada (7) - Japan (2) - Europe (40) - - France (3) - - Germany (17) - - The United Kingdom (10) - - Italy (1) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (13) - Latin America (5) - Middle East (3) For more information visit http://www.researchandmarkets.com/research/xf...onal_wound About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products
Business Wire - Fri Mar 14, 6:30AM CDT
Derma Sciences, Inc. (the "Company"
(Nasdaq SCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ended December 31, 2013. Highlights of the fourth quarter of 2013 and recent weeks include: Wound Debridement Products - Global Strategic Business Report
M2 - Wed Mar 12, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ffjwkx/wound_debridement) has announced the addition of the "Wound Debridement Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 35 companies including many key and niche players such as: - Advanced Medical Solutions Group plc - ArthroCare Corporation - Coloplast A/S - Derma Sciences, Inc. - Misonix, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends And Issues 3. Product Overview 4. Strategic Corporate Developments 5. Focus On Select Global Players 6. Global Market Perspective III. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/ff...ebridement About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 14th
Business Wire - Mon Mar 10, 6:30AM CDT
Derma Sciences, Inc. (the "Company"
(Nasdaq SCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on March 14, 2014 to discuss the financial results for the fourth quarter of 2013. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Derma Sciences to Present at the 26th Annual ROTH Conference
Business Wire - Tue Mar 04, 6:30AM CST
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound care, announced today that Edward J. Quilty, the Company's chairman and chief executive officer, will present a corporate overview and update at the 26th Annual ROTH Conference on March 11, 2014 at 3:30 p.m. Pacific time. The conference is being held at the Ritz Carlton, Laguna Niguel in Dana Point, Calif. from March 9 through March 12. Can Derma Sciences (DSCI) Continue to Rise? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 31, 6:33AM CST
Can Derma Sciences (DSCI) Continue to Rise?
Derma Sciences (DSCI) Jumps: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 8:21AM CST
Derma Sciences Inc. (DSCI) was a big mover last session, as the company saw its shares rise by over 6% on the day.
Derma Sciences Closes $86 Million Underwritten Public Offering of Common Stock, Including Full Over-Allotment
Business Wire - Wed Jan 29, 9:17AM CST
Derma Sciences, Inc. (the "Company"
(Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the closing of an underwritten public offering of 7,500,000 shares of common stock at a price to the public of $11.50 per share, which includes the exercise of the underwriters' option to purchase 978,261 shares of common stock to cover over-allotments. Piper Jaffray & Co. and Canaccord Genuity Inc. were joint bookrunning managers for the offering. Oppenheimer & Co. Inc. and Roth Capital Partners were financial advisors to the Company. International Wound Dressings Market - Forecasts to 2018
M2 - Wed Jan 29, 3:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/wgbxbp/wound_dressings) has announced the addition of the "International Wound Dressings Market - Forecasts to 2018" report to their offering. "International Wound Dressings Market - Forecasts to 2018", inspects the different types of segments and sub-segments within the market such as the product types such as traditional wound care which includes sutures, gauze tapes and sponges, surgical cotton swabs and tissue sealants etc. The details also include emerging and advanced technologies such as films, foam dressings, collagen, alginates, hydrocolloids and hydrogels. The market analysis includes the analysis for the major geographical regions; North America, Europe, Asia-Pacific and Rest of the World (RoW). The study entails the emerging economies and regional opportunities that will present themselves in the coming years. In addition, the research also includes the other regional factors that will influence the growth or decline of the market in these regions. The analysis covers a forecast period of 2012 - 2018 which includes the several milestones covered in all the years. This represents several aspects such as the political, economical, environmental, legal factors such as growth of economy, reimbursement and medical policies in various regions. The report is prepared in such a way so as to cover the focus areas of multiple stake-holders such as market players and manufacturers of wound care products, hospitals, doctors, other medical professionals, research institutes, venture capitalists and share holders of public companies. The report is expected to act as a influencing tool to enable stake-holders to make calculated strategic decisions related to their marketing, expansion and penetration, business strategies adopted by them. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Wound Dressings Market Analysis Chapter 4 Traditional Wound Dressings Market Chapter 5 Advanced Wound Dressings Market Chapter 6 Geographical Analysis Chapter 7 Company Profiles Companies Mentioned: - 3M Healthcare - BSN Medical GMBH and Co - Bristol-Myers Squibb - CONVATEC HEALTHCARE - Coloplast - Derma Sciences - Hollister - Johnson & Johnson - Kinetic Concepts - Medline Industries - Paul Hartmann - Smith & Nephew - Systagenix Wound Management For more information visit http://www.researchandmarkets.com/research/wg..._dressings
Nasdaq stocks posting largest volume increases
AP - Fri Jan 24, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Derma Sciences Announces Pricing of Underwritten Public Offering of Common Stock
Business Wire - Fri Jan 24, 8:00AM CST
Derma Sciences, Inc. (the "Company"
(Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the pricing of an underwritten public offering of 6,521,739 shares of common stock at a price to the public of $11.50 per share. The Company has granted the underwriters a 30-day option to purchase an additional 978,261 shares of common stock to cover over-allotments, if any. The offering is expected to close on or about January 29, 2014, subject to customary closing conditions. Derma Sciences Announces Commencement of Public Offering of Common Stock
Business Wire - Thu Jan 23, 3:01PM CST
Derma Sciences, Inc. (Nasdaq
SCI), a tissue regeneration company focused on advanced wound care, today announced that it intends to offer shares of its common stock in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. 2013 Report on the European Wound Care Management Market - Outlook and Forecasts to 2018
M2 - Thu Jan 23, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/x3flwl/europe_wound_care) has announced the addition of the "2013 Report on the European Wound Care Management Market - Outlook and Forecasts to 2018" report to their offering. "2013 Report on the European Wound Care Management Market - Outlook and Forecasts to 2018", provides key market data on the Europe Wound Care Management market - United Kingdom, Germany, France, Italy and Spain. The report provides value (USD million) data for all the market categories - Compression Therapy, Advanced Wound Management, Pressure Relief Devices, Wound Closure Devices, Traditional Wound Management, Ostomy Drainage Bags, Negative Pressure Wound Therapy (NPWT), Tissue Engineering, Wound Debridement Devices and Automated Suturing Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Key players covered in this report include Coloplast A/S, Paul Hartmann AG, Smith & Nephew Plc, ConvaTec Inc., Covidien plc, Molnlycke Health Care AB, Kinetic Concepts, Inc., ArjoHuntleigh, medi GmbH & Co. KG, Hill-Rom Holdings, Inc., SIGVARIS, Inc., B. Braun Melsungen AG, Hollister Incorporated, Ethicon, Inc., Takeda Pharmaceuticals International GmbH, Baxter International Inc., Laboratoires Urgo S.A. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Wound Care Management in Europe 4 Wound Care Management In Germany 5 Wound Care Management In France 6 Wound Care Management In United Kingdom 7 Wound Care Management In Italy 8 Wound Care Management In Spain 9 Overview of Key Companies in Europe Wound Care Management Market 10 Wound Care Management Market Pipeline Products 11 Financial Deals Landscape 12 Recent Developments 13 Appendix Companies Mentioned: - 3M Health Care - Advanced Medical Solutions Group - Baxter International - Bsn Medical - Coloplast - Convatec - Covidien - Derma Sciences - Igrobe Rodar - Invacare Corporation - Johnson & Johnson - Julius Zorn - Karomed Limited - Laboratoires Innothera - Laboratoires Urgo - Lohmann & Rauscher Gmbh & Co - Medela - Ossur - Paramount Bed - Paul Hartmann - Sidhil Limited - Smith & Nephew - Synergy Health - Systagenix Wound Management - Talley Group Limited - Thuasne For more information visit http://www.researchandmarkets.com/research/x3...wound_care
